A61K 39/0291
Yersinia
Official title: {Yersinia}
A61K39/0291 (Yersinia) appears on 64 US grants and 88 published applications in this corpus.
Search patents in A61K- Granted patents
- 64
- Published applications
- 88
- Assignees
- 57
- Inventors
- 133
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 3 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 1 |
| 2008 | 1 | 3 |
| 2009 | 0 | 0 |
| 2010 | 1 | 4 |
| 2011 | 0 | 5 |
| 2012 | 1 | 3 |
| 2013 | 2 | 4 |
| 2014 | 3 | 8 |
| 2015 | 9 | 10 |
| 2016 | 9 | 7 |
| 2017 | 3 | 3 |
| 2018 | 3 | 4 |
| 2019 | 6 | 4 |
| 2020 | 2 | 3 |
| 2021 | 4 | 5 |
| 2022 | 4 | 4 |
| 2023 | 3 | 2 |
| 2024 | 3 | 3 |
| 2025 | 3 | 8 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Immunomodulatory and oncolytic minicells and methods of use22 Sep 2026US 12,741,010 B2Vaxiion Therapeutics, Inc.
- Gut bacteria derived microvesicles for vaccine delivery16 Jun 2026US 12,653,877 B2Quadram Institute Bioscience
- Immunogenicity of a CpG-adjuvanted recombinant plague vaccine22 Jul 2025US 12,364,745 B2Dynavax Technologies Corporation
- Methods and compositions related to the next generation vaccine17 Jun 2025US 12,331,085 B2University of Kansas
- Self-adjuvanting Yersinia outer membrane vesicle as a vaccine against plague, anthrax and pseudomonas infection4 Feb 2025US 12,214,030 B2Albany Medical College
- A broadly protective prophylactic vaccine against pseudomonas aeruginosa24 Sep 2026US 2026/0284172 A1University of Kansas
- Compositions, methods, and uses for polynucleotide formulations for drying and prolonged storage15 Jan 2026US 2026/0014251 A1VitriVax, Inc.
- Immunogenicity of a cpg-adjuvanted recombinant plague vaccine27 Nov 2025US 2025/0360190 A1Dynavax Technologies Corporation
- Thermostable particle-based compositions and manufacturing process4 Sep 2025US 2025/0275922 A1Iowa State University Research Foundation, Inc.
- Methods and compositions related to the next generation vaccine4 Sep 2025US 2025/0277005 A1University of Kansas
Most cited
By later US patents
- Antigen library immunization76US 6,541,011 B2Maxygen, Inc. · 2003
- Use of flagellin in the immunotherapy of Yersinia pestis35US 7,794,731 B2Wake Forest University Health Sciences · 2010
- Method for the treatment of water-living animals with health modifying agents27US 4,333,922 A1982
- Method for the treatment of water-living animals with health modifying agents20US 4,112,946 A1978
- Immunomodulatory minicells and methods of use17US 9,566,321 B2Vaxiion Therapeutics, Inc. · 2017